Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...
TRE-515 has received FDA fast track designation for treating PSMA-positive mCRPC, aiming to accelerate its development and availability. The drug is being tested in combination with Pluvicto, a ...
For years, Laurel, Maryland, resident Michael Cominski coped with the effects of an enlarged prostate. He woke up as many as five times a night to use the bathroom, and it began to take a toll.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results